7 results found.

Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using MV-NIS; cyclophosphamide; I-123 prior MV-NIS; I-123 post MV-NIS; Liothyronine

Mayo Clinic - Recruiting 18 years or older.
- Phase I Trial of Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With or Without Cyclophosphamide, in Patients With Recurrent or Refractory Multiple Myeloma.
MV-NIS; cyclophosphamide; I-123 prior MV-NIS; I-123 post MV-NIS; Liothyronine

Leukemia, Lymphoma, or Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using busulfan; cyclophosphamide; Stem cell infusion; Total body irradiation

Masonic Cancer Center, University of Minnesota - Recruiting N/A to 55 years.
- Unrelated or Partially Matched Allogeneic Donor Stem Cells for Lymphoma, Myeloma, and Chronic Lymphocytic Leukemia.
busulfan; cyclophosphamide; Stem cell infusion; Total body irradiation

Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using bortezomib; dexamethasone

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase II Trial of Twice Weekly Induction Followed by Once Weekly IV Velcade (Bortezomib) With Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Following at Least 1 Prior Therapy.
bortezomib; dexamethasone

Brain and Central Nervous System Tumors, Chronic Myeloproliferati Clinical Trial using 3'-deoxy-3'-[18F]fluorothymidine

Barbara Ann Karmanos Cancer Institute - Recruiting 18 years or older.
- Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET).
3'-deoxy-3'-[18F]fluorothymidine

Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Clinical Trial using assessment of therapy complications

Southwest Oncology Group - Recruiting N/A or older.
- S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment.
assessment of therapy complications

Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using clonality analysis; polymerase chain reaction; protein analysis; biologic sample preservation procedure; laboratory biomarker analysis; fluorescence spectroscopy; quality-of-life assessment

Boston Medical Center - Recruiting 18 years or older.
- Data, Tissue, Blood, and Urine Repository for Amyloid Diseases.
clonality analysis; polymerase chain reaction; protein analysis; biologic sample preservation procedure; laboratory biomarker analysis; fluorescence spectroscopy; quality-of-life assessment

Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using bortezomib; hydroxychloroquine; immunologic technique; laboratory biomarker analysis; mass spectrometry; pharmacological study; biopsy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I/II Trial of Hydroxychloroquine Added to Bortezomib for Relapsed/Refractory Myeloma.
bortezomib; hydroxychloroquine; immunologic technique; laboratory biomarker analysis; mass spectrometry; pharmacological study; biopsy